Análise da resposta imune celular de pacientes com tuberculose pulmonar ativa contra os antígenos recombinantes MPT-51, GLcB, ESAT-6, Ag 85A e a proteína do filtrado de cultura (CFP) de mycobacterium tuberculosis

• Autor(a) principal: VASCONCELOS JUNIOR, Arioldo Carvalho
• Data de Publicação: 2008
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tde/1818
• topic: Tuberculose; mycobacterium tuberculosis; antígenos recombinantes; resposta imune celular; Tuberculosis; mycobacterium tuberculosis; recombinant antigens; cellular immune response; CNPQ::CIENCIAS DA SAUDE::MEDICINA

This work characterized the specific cellular immune response of TCD4 and TCD8 lymphocytes against recombinant Mycobacterium tuberculosis at the Hospital Anuar Auad, Goiania Brazil, and constituted of two experimental groups: 1) 22 active TB patients with positive acid fast aputum, X-ray indicative of tuberculosis, smear culture positive for M. tuberculosis and HIV negative. 2) 15 sex and age matched healthy controls, tuberculin skin test and HIV negative. Venous blood was drawn and processed to obtain PBMC that were cultivated for 96 hours with the specific antigens (1mg/106 cells). TCD8 and TCD4 cells were analyzed by flow citometry for IL-10 and IFN-g production. In general, the percentage of positive TCD4 and TCD8 cells for IFN-g and IL-10 were superior among the TB patients. Additionally, TCD4+IFNg+ (5,63±2,43) and IL-10+ (5,83± 2,19) cells were significantly higher in TB patients than in healthy controls (TCD4+IFNg+ =1,75±0,71 and IL-10+ =1,47±0,90), (p<0,01). Regarding the percentage of TCD8 cells, a higher percentage of IFNg+ (4,33±1,45) and IL-10+ (4,01±1,14) among TB patients than controls (TCD8+IFNg+ = 1,49±0,42 and IL- 10+ 1,62±0,59) was observed (p<0,01). TB treatment did not alter the response to the tested antigens immediately after the treatment initiation. In conclusion, the recombinant antigens MPT-51, ESAT-6, GLcB, Ag85A were recognized by the specific immune response of active TB patients. Key words: Tuberculosis, Mycobacterium tuberculosis, Recombinant antigens, Cellular immune response. to the tested antigens immediately after the treatment initiation. In conclusion, the recombinant antigens MPT-51, ESAT-6, GLcB, Ag85A were recognized by the specific immune response of active TB patients.